Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial

Autor: Jebb, Susan A, Ahern, Amy L, Olson, Ashley D, Aston, Louise M, Holzapfel, Christina, Stoll, Julia, Amann-Gassner, Ulrike, Simpson, Annie E, Fuller, Nicholas R, Pearson, Suzanne, Lau, Namson S, Mander, Adrian P, Hauner, Hans, Caterson, Ian D

Publikováno v: In The Lancet 2011 378(9801):1485-1492

Weight Watchers on prescription: An observational study of weight change among adults referred to Weight Watchers by the NHS

Autor: Aston Louise M, Olson Ashley D, Ahern Amy L, Jebb Susan A

Publikováno v: BMC Public Health, Vol 11, Iss 1, p 434 (2011)

Abstract Background The scale of overweight and obesity in the UK places a considerable burden on the NHS. In some areas the NHS has formed partnerships with commercial companies to offer weight management services, but there has been little evaluati

Externí odkaz: https://doaj.org/article/06b1f7e2bf804b97a9ceef8f330c3fc1

Weight Watchers on prescription: An observational study of weight change among adults referred to Weight Watchers by the NHS.

Autor: Ahern, Amy L.¹, Olson, Ashley D.¹, Aston, Louise M.¹, Jebb, Susan A. Susan.Jebb@mrc-hnr.cam.ac.uk

Publikováno v: BMC Public Health. 2011, Vol. 11 Issue 1, p434-438. 5p.

Limiting Cumulative HIV Viremia Copy-Years by Early Treatment Reduces Risk of AIDS and Death

Autor: Olson, Ashley D., Walker, A. Sarah, Suthar, Amitabh B., Sabin, Caroline A., Bucher, Heiner C., Jarrín, Inmaculada, Moreno, Santiago, Pérez-Hoyos, Santiago, Porter, Kholoud, Ford, Deborah, Universitat Autònoma de Barcelona

Publikováno v: Journal of Acquired Immune Deficiency Syndromes (1999)
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
Repisalud
Instituto de Salud Carlos III (ISCIII)
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

Supplemental Digital Content is Available in the Text.
Background: Viremia copy-years (VCY), a time-updated measure of cumulative HIV exposure, predicts AIDS/death; although its utility in deciding when to start combination antiretroviral therap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c78e8ad247b4173a00e2536866a6295
https://pubmed.ncbi.nlm.nih.gov/27116045

Evaluation of Rapid Progressors in HIV Infection as an Extreme Phenotype

Autor: Olson, Ashley D., Guiguet, Marguerite, Zangerle, Robert, Gill, John, Perez-Hoyos, Santiago, Lodi, Sara, Ghosn, Jade, Dorrucci, Maria, Johnson, Anne, Sannes, Mette, Moreno, Santiago, Porter, Kholoud

Publikováno v: Journal of acquired immune deficiency syndromes (1999), 67(1), 15-21. Lippincott Williams and Wilkins

Design: Rapid CD4 cell loss represents an HIV phenotype used to identify causal variants of accelerated disease progression. The optimal rate and threshold for identifying this extreme phenotype in recently infected individuals is unclear. Methods: U

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::c8f4c7950e80728fd9b1a693a2594504
https://pure.amc.nl/en/publications/evaluation-of-rapid-progressors-in-hiv-infection-as-an-extreme-phenotype(fa0ad069-2435-4db1-b2fb-dfc640c23cdd).html